Daily Market Reports | Oct 26 2023
This story features 29METALS LIMITED, and other companies. For more info SHARE ANALYSIS: 29M
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
29M A11 A1N ALL AMP ARB AVH BHP BPT CCP CCR CNB COI CTD (3) CTT CUV EEG EVN (3) EVT EXP GOZ HDN ILU IMD INA JHX LIC LNW LRK MAP MYX (2) NCK (2) NST NWL (2) PLS PMT PPS (3) RDY (2) RED (2) RFG RWC STO THL (2) TLX (2) TRS VIT WDS
29M 29METALS LIMITED
Copper – Overnight Price: $0.60
Jarden rates ((29M)) as Upgrade to Overweight from Neutral (2) –
Jarden returns from research restriction on 29Metals with an Overweight rating and upgrades the target price to 80c from 71c.
The broker says everything has changed for the company following the derisking of its balance sheet and upgraded cash flow and earnings forecasts.
Jarden shaves its 2023 and 2024 copper price forecasts but expects strong growth in the company's copper and zinc volumes now capital constraints have been removed.
The broker forecasts a four-year compound annual growth rate in copper production of 6%.
This report was published on October 19, 2023.
Target price is $0.80 Current Price is $0.60 Difference: $0.2
If 29M meets the Jarden target it will return approximately 33% (excluding dividends, fees and charges).
Current consensus price target is $0.79, suggesting upside of 32.1%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 20.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 2.90.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -20.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 4.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 14.29.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -9.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
A11 ATLANTIC LITHIUM LIMITED.
New Battery Elements – Overnight Price: $0.40
Canaccord Genuity rates ((A11)) as Speculative Buy (1) –
Atlantic Lithium has announced that the Ghanaian Government has awarded the mining lease for the Ewoyaa lithium project. This is a key milestone in the development process, Canaccord Genuity suggests, with only environmental approval remaining as the last major licensing hurdle.
The broker views Atlantic as one of the highest quality hard-rock developers globally. The Ewoyaa project has low opex, low capex, simple processing and a fast path to production.
Speculative Buy retained, target $1.40.
This report was published on October 25, 2023.
Target price is $1.40 Current Price is $0.40 Difference: $1.005
If A11 meets the Canaccord Genuity target it will return approximately 254% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 98.75.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 131.67.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
A1N ARN MEDIA LIMITED
Print, Radio & TV – Overnight Price: $0.81
Canaccord Genuity rates ((A1N)) as Buy (1) –
Teaming up with Anchorage Capital Partners, ARN Media's approach on peer Southern Cross Media Group ((SXL)) potentially remakes the business as a larger, more profitable one with a better growth outlook, Canaccord Genuity suggests.
While the broker does not have visibility on the earnings which may accrue to ARN Media from the transaction at this time, a pro rata split would see ARN add nearly $30m earnings for its $165m investment, although Canaccord expects that this figure could be much higher given the number of regional radio stations changing hands.
Buy and $1.20 target retained.
This report was published on October 25, 2023.
Target price is $1.20 Current Price is $0.81 Difference: $0.39
If A1N meets the Canaccord Genuity target it will return approximately 48% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 7.00 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 8.64%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.10.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 9.00 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 11.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.10.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ALL ARISTOCRAT LEISURE LIMITED
Gaming – Overnight Price: $40.37
Jarden rates ((ALL)) as Overweight (2) –
Jarden believes there is upside operational earnings risk for Aristocrat Leisure and Buy-rated Light & Wonder ((LNW)) due to strong gross gaming revenue (GGR) growth, well-funded cashed up casino customers and strong replacement demand.
The broker also sees growth across both Gaming Operations (rental model) and Outright Sales and expects both companies will take market share. The gaming industry is considered strong after ten consecutive quarters of GGR growth, and is arguably resilient.
The Overweight rating and $41.90 target are maintained for Aristocrat Leisure.
This report was published on October 20, 2023.
Target price is $41.90 Current Price is $40.37 Difference: $1.53
If ALL meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $44.66, suggesting upside of 10.6%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 59.00 cents and EPS of 197.90 cents.
At the last closing share price the estimated dividend yield is 1.46%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.40.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 195.2, implying annual growth of 36.6%.
Current consensus DPS estimate is 64.1, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 20.7.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 69.00 cents and EPS of 197.90 cents.
At the last closing share price the estimated dividend yield is 1.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.40.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 210.1, implying annual growth of 7.6%.
Current consensus DPS estimate is 73.5, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 19.2.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AMP AMP LIMITED
Wealth Management & Investments – Overnight Price: $1.05
Jarden rates ((AMP)) as Neutral (3) –
AMP's September-quarter witnessed record net outflows of -$5.1bn from its wealth business due to a preannounced corporate super mandate loss.
After adjusting for this, Jarden observes that flows were still weak, assets under management falling -2.6% for the quarter.
More concerning for the broker was the compression in net interest margins, revised FY23 guidance implying a -15% fall from 1.39% at June 30 to 1.2% for the December half.
EPS forecasts fall -2.4% in FY23; and -2.2% for FY24.
Neutral rating retained to reflect weak core fundamentals. Target price falls to $1.22 from $1.25.
This report was published on October 19, 2023.
Target price is $1.22 Current Price is $1.05 Difference: $0.165
If AMP meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $1.18, suggesting upside of 12.1%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 5.00 cents and EPS of 6.50 cents.
At the last closing share price the estimated dividend yield is 4.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 7.4, implying annual growth of N/A.
Current consensus DPS estimate is 4.6, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 14.3.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 5.50 cents and EPS of 8.20 cents.
At the last closing share price the estimated dividend yield is 5.21%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.87.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.0, implying annual growth of 8.1%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 5.9%.
Current consensus EPS estimate suggests the PER is 13.2.
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ARB ARB CORPORATION LIMITED
Automobiles & Components – Overnight Price: $30.43
Wilsons rates ((ARB)) as Overweight (1) –
ARB Corp's September-quarter trading update revealed subdued sales growth but Wilsons says strong net-profit-after-tax growth suggests improvement in gross margins.
Wilsons is going down the quality over quantity path, observing strong domestic orders, a hastening in the US retail strategy, and new operating equipment manufacturer orders, and remains a long-term fan.
No specific guidance was provided. Overweight rating retained. Target price eases to $35.30 from $35.88.
This report was published on October 20, 2023.
Target price is $35.30 Current Price is $30.43 Difference: $4.87
If ARB meets the Wilsons target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $31.01, suggesting upside of 1.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 71.00 cents and EPS of 123.00 cents.
At the last closing share price the estimated dividend yield is 2.33%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.74.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 118.8, implying annual growth of 10.1%.
Current consensus DPS estimate is 64.4, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 25.6.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 81.00 cents and EPS of 137.50 cents.
At the last closing share price the estimated dividend yield is 2.66%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.13.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 131.6, implying annual growth of 10.8%.
Current consensus DPS estimate is 71.3, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 23.1.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AVH AVITA MEDICAL INC
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $3.14
Wilsons rates ((AVH)) as Overweight (1) –
Avita Medical has secured $90m of non-dilutive debt financing with OrbiMed, committing to self-commercialise the Vitiligo opportunity and support its burns and trauma division, at an interest of 12% to 13% observes Wilsons.
$40m has been secured immediately, and an additional US$50m has been made available in two US$25m tranches conditional on revenue thresholds being met: US$75m in trailing by June 2025, and US$100m by June 2026. Wilsons doubts the final tranche will be needed.
Management expects Avita's net interest expense, after accounting for interest income, will be 7% to 8%.
Management also confirmed September-quarter revenue of US$13.5m and gross margins outpaced Wilson's forecasts, implying quarter-on-quarter growth of more than 17%, and year-on-year growth of 80%.
Management advises it is now targeting profitability in FY25, compared with Wilson's forecast of FY26.
Wilsons says the news has material implications (it had been expecting a capital raising and a later shift to profitability) for its forecasts and is reviewing its modeling.
Until then, the broker retains its Overweight rating and $6.34 target.
This report was published on October 20, 2023.
Target price is $6.34 Current Price is $3.14 Difference: $3.2
If AVH meets the Wilsons target it will return approximately 102% (excluding dividends, fees and charges).
Current consensus price target is $6.40, suggesting upside of 103.7%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 86.24 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 3.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -91.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents.
How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -33.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BHP BHP GROUP LIMITED
Bulks – Overnight Price: $44.72
Goldman Sachs rates ((BHP)) as Buy (1) –
A stronger than expected September quarter from BHP Group, Goldman Sachs noting the company reported better-than-expected copper and nickel production, and iron ore shipments.
Offsetting this were weaker-than-expected met coal production and sales, driven by extended maintenance downtime at Peak Downs and Goonyella. Full year production guidance is retained, although Goldman Sachs lowers its earnings per share forecast -2%.
The Buy rating and target price of $46.50 are retained.
This report was published on October 18, 2023.
Target price is $46.50 Current Price is $44.72 Difference: $1.78
If BHP meets the Goldman Sachs target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $44.87, suggesting upside of 0.3%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 183.65 cents and EPS of 367.30 cents.
At the last closing share price the estimated dividend yield is 4.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.18.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 410.0, implying annual growth of N/A.
Current consensus DPS estimate is 241.1, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 10.9.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 167.09 cents and EPS of 335.69 cents.
At the last closing share price the estimated dividend yield is 3.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.32.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 448.9, implying annual growth of 9.5%.
Current consensus DPS estimate is 269.8, implying a prospective dividend yield of 6.0%.
Current consensus EPS estimate suggests the PER is 10.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BPT BEACH ENERGY LIMITED
Crude Oil – Overnight Price: $1.48
Jarden rates ((BPT)) as Overweight (2) –
Beach Energy has found gas at the Tarantula Deep 1 exploration well in the Perth Basin. Jarden infers from the size of the fault compartment that the volume is likely a fraction of the Beharra Springs Deep volume.
More work is required to delineate the amount of gas in separate fault compartments, observes Jarden. Ditto for Waitsia.
Overweight rating and $1.85 target price retained.
This report was published on October 19, 2023.
Target price is $1.85 Current Price is $1.48 Difference: $0.37
If BPT meets the Jarden target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $1.80, suggesting upside of 21.3%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 6.50 cents and EPS of 19.90 cents.
At the last closing share price the estimated dividend yield is 4.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.44.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 17.7, implying annual growth of 0.7%.
Current consensus DPS estimate is 4.1, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 8.4.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 14.50 cents and EPS of 32.50 cents.
At the last closing share price the estimated dividend yield is 9.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.55.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.7, implying annual growth of 45.2%.
Current consensus DPS estimate is 9.8, implying a prospective dividend yield of 6.6%.
Current consensus EPS estimate suggests the PER is 5.8.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CCP CREDIT CORP GROUP LIMITED
Business & Consumer Credit – Overnight Price: $12.14
Canaccord Genuity rates ((CCP)) as Hold (3) –
Operating performance within Credit Corp’s US purchased debt ledgers business deteriorated into September, leading management to amend its FY24 profit guidance and impair some of the carrying value (-14%) of its US PDL assets.
Canaccord Genuity notes the company recorded year on year collections growth of 10% in July and August and then flat growth in September, but this was below management and market expectations.
This is disappointing, the broker suggests, given the level of capital outlaid into US PDLs in recent years and suggests materially below-par collection efficiency and return on equity. Share price de-rating reflects the level of earnings uncertainty.
Target falls to $13.20 from $21.30, Hold retained.
This report was published on October 25, 2023.
Target price is $13.20 Current Price is $12.14 Difference: $1.06
If CCP meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $15.02, suggesting upside of 23.7%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 48.00 cents and EPS of 120.00 cents.
At the last closing share price the estimated dividend yield is 3.95%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.12.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 79.4, implying annual growth of -40.8%.
Current consensus DPS estimate is 40.7, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 15.3.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 67.00 cents and EPS of 134.00 cents.
At the last closing share price the estimated dividend yield is 5.52%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.06.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 118.8, implying annual growth of 49.6%.
Current consensus DPS estimate is 60.3, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 10.2.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CCR CREDIT CLEAR LIMITED
Diversified Financials – Overnight Price: $0.18
Petra Capital rates ((CCR)) as Buy (1) –
Credit Clear's September-quarter result appears to have pleased Petra Capital, cash from operations up 50% on the previous September quarter leading to a cash-on-hand September-quarter close of $12.2m.
The broker observes that strong growth in the company's higher margin digital collections continues to outpace traditional debt recovery.
Revisiting the company after its May capital raise, the broker cuts its target price to 40c from 50c. Buy rating retained.
This report was published on October 19, 2023.
Target price is $0.40 Current Price is $0.18 Difference: $0.22
If CCR meets the Petra Capital target it will return approximately 122% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 1.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 12.00.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 30.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CNB CARNABY RESOURCES LIMITED
Mining – Overnight Price: $0.79
Petra Capital rates ((CNB)) as Buy (1) –
Petra Capital says Glencore's decision to close its Mt Isa Mines and copper concentrator in FY25 creates uncertainty around toll milling for Carnaby Resources' Greater Duchess project.
While the broker observes the concentrator is a valuable asset which is likely to be well bid, it nonetheless adopts a -25% discount to account for increased development risk.
Buy rating retained. Target price falls to $1.50 from $1.89.
This report was published on October 19, 2023.
Target price is $1.50 Current Price is $0.79 Difference: $0.715
If CNB meets the Petra Capital target it will return approximately 91% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
COI COMET RIDGE LIMITED
NatGas – Overnight Price: $0.16
Petra Capital rates ((COI)) as Buy (1) –
As Comet Ridge progresses its large scale CSG assets in the South Bowen Basin, Petra Capital reconciles the company's working interests at each of its projects against the company's strategy.
The broker also cuts its future equity price assumption.
EPS forecasts are negative for FY24 and FY25.
Buy rating retained.Target price falls to 38c from 40c.
This report was published on October 20, 2023.
Target price is $0.38 Current Price is $0.16 Difference: $0.22
If COI meets the Petra Capital target it will return approximately 138% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 4.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 4.00.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 6.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 2.67.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CTD CORPORATE TRAVEL MANAGEMENT LIMITED
Travel, Leisure & Tourism – Overnight Price: $17.00
Goldman Sachs rates ((CTD)) as Buy (1) –
Corporate Travel Management's 1Q earnings (EBITDA) were in line with Goldman Sachs' forecast, while the revenue run-rate was a miss.
Management reaffirmed it was on track to meet consensus forecasts for revenue and underlying earnings.
The company aims for a mid-teens EPS compound annual growth rate (CAGR) beyond FY25, which exceeds the broker's mid-high single digit forecast.
Based on an ongoing recovery for travel, and rising industry penetration and concentration toward SME travel management, Goldman Sachs retains its Buy rating. Target $20.50.
This report was published on October 20, 2023.
Target price is $20.50 Current Price is $17.00 Difference: $3.5
If CTD meets the Goldman Sachs target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $23.16, suggesting upside of 36.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 EPS of 101.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.83.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 106.6, implying annual growth of 100.9%.
Current consensus DPS estimate is 50.4, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 15.9.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 EPS of 121.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 128.6, implying annual growth of 20.6%.
Current consensus DPS estimate is 62.0, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 13.2.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Jarden rates ((CTD)) as Buy (1) –
Jarden leaves its Buy rating and $23 target unchanged following a "good" 1Q update by Corporate Travel Management. Year-on-year revenue and earnings (EBITDA) rose by 36% and 157%, respectively.
These outcomes were ahead of the FY24 guidance (average) run-rates of 23% and 56%, notes the analyst, providing increased confidence guidance will be met.
Demand remains robust with easing airfares stimulating demand, explains the broker, though rising fuel costs are creating earnings pressure for some airlines, potentially forcing near-term ticket pricing higher.
This report was published on October 20, 2023.
Target price is $23.00 Current Price is $17.00 Difference: $6
If CTD meets the Jarden target it will return approximately 35% (excluding dividends, fees and charges).
Current consensus price target is $23.16, suggesting upside of 36.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 EPS of 104.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.21.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 106.6, implying annual growth of 100.9%.
Current consensus DPS estimate is 50.4, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 15.9.
Forecast for FY25:
Jarden forecasts a full year FY25 EPS of 117.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 128.6, implying annual growth of 20.6%.
Current consensus DPS estimate is 62.0, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 13.2.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((CTD)) as Overweight (1) –
Corporate Travel Management's 1Q trading update revealed ongoing momentum from new client wins and demonstrated to Wilsons activity across large clients in North America, A&NZ and the EU is gradually improving.
Overall, the broker feels the update fell somewhere between on track with expectations, to being incrementally positive.
Compared to the previous corresponding period, group revenue, (EBITDA) earnings and the earnings margin increased by 36%, 157% and 15.9%, respectively.
No formal guidance was provided. Overweight. Target $21.31.
This report was published on October 20, 2023.
Target price is $21.31 Current Price is $17.00 Difference: $4.31
If CTD meets the Wilsons target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $23.16, suggesting upside of 36.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 85.50 cents and EPS of 74.90 cents.
At the last closing share price the estimated dividend yield is 5.03%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.70.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 106.6, implying annual growth of 100.9%.
Current consensus DPS estimate is 50.4, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 15.9.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 26.80 cents and EPS of 25.00 cents.
At the last closing share price the estimated dividend yield is 1.58%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 68.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 128.6, implying annual growth of 20.6%.
Current consensus DPS estimate is 62.0, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 13.2.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CTT CETTIRE LIMITED
Apparel & Footwear – Overnight Price: $2.58
Petra Capital rates ((CTT)) as Buy (1) –
Cettire's September-quarter result appears to have met Petra Capital's forecasts, the company posting strong net revenue and earnings (EBITDA) growth.
The broker observes the company's underlying trajectory remains robust.
Buy rating and $4.15 target price retained.
This report was published on October 19, 2023.
Target price is $4.15 Current Price is $2.58 Difference: $1.57
If CTT meets the Petra Capital target it will return approximately 61% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of 6.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.94.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 9.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.74.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CUV CLINUVEL PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $15.47
Wilsons rates ((CUV)) as Overweight (1) –
Clinuvel Pharmaceuticals has announced initiation of a Phase III trial in vitiligo (CUV105) using the approved drug Scenesse.
Wilsons points out expansion of Scenesse into other indications such as vitiligo provides material leverage and growth opportunities to Clinuvel’s existing core business.
Supporting the broker's bullish outlook for the drug – used for severely depigmented, darker skinned vitiligo patients – is compelling Phase II efficacy data from the CUV102 and 103 studies from several years ago.
The $28.13 target and Overweight rating are retained.
This report was published on October 19, 2023.
Target price is $28.13 Current Price is $15.47 Difference: $12.66
If CUV meets the Wilsons target it will return approximately 82% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 8.00 cents and EPS of 66.70 cents.
At the last closing share price the estimated dividend yield is 0.52%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.19.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 11.80 cents and EPS of 78.40 cents.
At the last closing share price the estimated dividend yield is 0.76%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.73.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
EEG EMPIRE ENERGY GROUP LIMITED
Energy – Overnight Price: $0.13
Canaccord Genuity rates ((EEG)) as Buy (1) –
Having suffered a "perfect storm" in the second half FY23, Empire Energy has begun its recovery, Canaccord Genuity notes, with the AGM update guiding to improved margins in its Agency businesses and revenue growth for OBMedia guided for the second quarter FY24.
The stock remains modestly valued, the broker suggests, but potentially faces an important catalyst as a strategic review into OBMedia concludes.
Buy retained, target falls to $2.60 from $2.70.
This report was published on October 25, 2023.
Target price is $2.60 Current Price is $0.13 Difference: $2.47
If EEG meets the Canaccord Genuity target it will return approximately 1900% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 9.00 cents and EPS of 24.00 cents.
At the last closing share price the estimated dividend yield is 69.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 0.54.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 11.00 cents and EPS of 28.00 cents.
At the last closing share price the estimated dividend yield is 84.62%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 0.46.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
EVN EVOLUTION MINING LIMITED
Gold & Silver – Overnight Price: $3.62
Canaccord Genuity rates ((EVN)) as Buy (1) –
Lower production at Red Lake has seen Evolution Mining's group gold production for the September quarter miss Canaccord Genuity's expectations at only 158,000 ounces.
The broker anticipates a 10% production increase and -6% cost decrease in the December quarter, and that production and costs will continue to improve over the financial year as the company approaches higher grades at Cowal underground and Upper Campbell.
The Buy rating and target price of $4.00 are retained.
This report was published on October 18, 2023.
Target price is $4.00 Current Price is $3.62 Difference: $0.38
If EVN meets the Canaccord Genuity target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $3.69, suggesting upside of 2.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 5.00 cents and EPS of 25.00 cents.
At the last closing share price the estimated dividend yield is 1.38%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.48.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 28.5, implying annual growth of 219.9%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 11.00 cents and EPS of 36.00 cents.
At the last closing share price the estimated dividend yield is 3.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.06.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 29.6, implying annual growth of 3.9%.
Current consensus DPS estimate is 12.0, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 12.2.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Goldman Sachs rates ((EVN)) as Buy (1) –
While Evolution Mining has reported a soft first quarter, with production and sales a miss for Goldman Sachs given low production from Cowal, the broker notes full year guidance was retained and the company continues to report drilling success across its portfolio.
Goldman Sachs is anticipated net debt and gearing will peak for Evolution Mining in the December half, ahead of significant deleveraging.
The Buy rating is retained and the target price increases to $3.80 from $3.70.
This report was published on October 18, 2023.
Target price is $3.80 Current Price is $3.62 Difference: $0.18
If EVN meets the Goldman Sachs target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $3.69, suggesting upside of 2.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 6.00 cents and EPS of 34.00 cents.
At the last closing share price the estimated dividend yield is 1.66%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.65.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 28.5, implying annual growth of 219.9%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 8.00 cents and EPS of 40.00 cents.
At the last closing share price the estimated dividend yield is 2.21%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 29.6, implying annual growth of 3.9%.
Current consensus DPS estimate is 12.0, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 12.2.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Jarden rates ((EVN)) as Neutral (3) –
While the return of Ernest Henry to full production improved operating cash flow, 1Q results for Evolution Mining missed forecasts by Jarden and consensus by -14% and -11%, respectively.
Free cash flow generation was weak, explains the broker, due to a negative shift in working capital and a build in receivables at Ernest Henry.
Management's production and capex guidance is unchanged, though Jarden points out a record performance will be required over the balance of the financial year to meet these targets.
The broker's Neutral rating is unchanged and the target eases to $3.11 from $3.17.
This report was published on October 20, 2023.
Target price is $3.11 Current Price is $3.62 Difference: minus $0.51 (current price is over target).
If EVN meets the Jarden target it will return approximately minus 14% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $3.69, suggesting upside of 2.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 13.00 cents and EPS of 26.00 cents.
At the last closing share price the estimated dividend yield is 3.59%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.92.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 28.5, implying annual growth of 219.9%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 13.00 cents and EPS of 26.30 cents.
At the last closing share price the estimated dividend yield is 3.59%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.76.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 29.6, implying annual growth of 3.9%.
Current consensus DPS estimate is 12.0, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 12.2.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
EVT EVT LIMITED
Travel, Leisure & Tourism – Overnight Price: $10.40
Jarden rates ((EVT)) as Overweight (2) –
As the actors' strike continues impacting on the box office, Jarden expects EVT Ltd's Cinema division will also be negatively affected, offset by a solid near-term outlook for Hotels. A longer-term recovery is still anticipated for Cinemas.
Industry feedback suggests growth in revenue per average room (RevPar) over the remainder of 2023, partly due to growing occupancy in Sydney and strong demand in Melbourne, offset by increased supply, explains the broker.
The target falls to $12.46 from $12.54. Overweight.
This report was published on October 20, 2023.
Target price is $12.46 Current Price is $10.40 Difference: $2.06
If EVT meets the Jarden target it will return approximately 20% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 EPS of 43.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.85.
Forecast for FY25:
Jarden forecasts a full year FY25 EPS of 52.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.85.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
EXP EXPERIENCE CO LIMITED
Travel, Leisure & Tourism – Overnight Price: $0.20
Canaccord Genuity rates ((EXP)) as Buy (1) –
Experience Co's trading update was encouraging with solid Sep Q trading continuing into October, and combined with supportive industry anecdotes gives Canaccord Genuity confidence in its forecasts, which call for a sharply improving earnings profile over the next 12-24 months.
Chinese visitation at key experiences spiked during Golden Week. The dynamic has been turning in favour of holiday visitation in recent
months and in the broker's view provides some comfort in the near-term outlook.
Buy and 33c target retained.
This report was published on October 25, 2023.
Target price is $0.33 Current Price is $0.20 Difference: $0.125
If EXP meets the Canaccord Genuity target it will return approximately 61% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
GOZ GROWTHPOINT PROPERTIES AUSTRALIA
Infra & Property Developers – Overnight Price: $2.10
Moelis rates ((GOZ)) as Buy (1) –
Growthpoint Properties Australia's portfolio wide occupancy crept 2 percentage points higher to 95% over the September quarter, with the company continuing to make progress on leasing key vacancies at 5 Murray Rose and Sydney Olympic Park.
Gearing lifted to 37.7%, but Moelis points out this remains at the lower end of target range. The broker finds the company well positioned to endure interest rate headwinds, but warns investors will need to be patient in waiting for a return to a fair value share price.
The Buy rating is retained and the target price decreases to $3.43 from $3.69.
This report was published on October 22, 2023.
Target price is $3.43 Current Price is $2.10 Difference: $1.33
If GOZ meets the Moelis target it will return approximately 63% (excluding dividends, fees and charges).
Current consensus price target is $3.11, suggesting upside of 47.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 19.30 cents and EPS of 22.90 cents.
At the last closing share price the estimated dividend yield is 9.19%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.17.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.7, implying annual growth of N/A.
Current consensus DPS estimate is 20.0, implying a prospective dividend yield of 9.5%.
Current consensus EPS estimate suggests the PER is 9.7.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 19.90 cents and EPS of 23.40 cents.
At the last closing share price the estimated dividend yield is 9.48%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.97.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 23.7, implying annual growth of 9.2%.
Current consensus DPS estimate is 20.9, implying a prospective dividend yield of 10.0%.
Current consensus EPS estimate suggests the PER is 8.9.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
HDN HOMECO DAILY NEEDS REIT
REITs – Overnight Price: $1.07
Moelis rates ((HDN)) as Buy (1) –
Consumer spending on furniture and household equipment has declined -12% year-on-year as of August, with Moelis describing the recent weakness in household goods retail as potential "early signs the consumer is starting to crack".
The broker points out HomeCo Daily Needs REIT may be so far insulated from this given its better quality centres, but sees downside risk ahead and will be paying close attention to tenant quarterlies.
Despite this, Moelis finds HomeCo Daily Needs REIT a compelling investment, largely driven by its development pipeline. The Buy rating is retained and the target price decreases to $1.35 from $1.43.
This report was published on October 18, 2023.
Target price is $1.35 Current Price is $1.07 Difference: $0.28
If HDN meets the Moelis target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $1.33, suggesting upside of 24.1%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 8.30 cents and EPS of 8.60 cents.
At the last closing share price the estimated dividend yield is 7.76%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.44.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.7, implying annual growth of 76.1%.
Current consensus DPS estimate is 8.2, implying a prospective dividend yield of 7.7%.
Current consensus EPS estimate suggests the PER is 12.3.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 8.30 cents and EPS of 8.80 cents.
At the last closing share price the estimated dividend yield is 7.76%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.16.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.0, implying annual growth of 3.4%.
Current consensus DPS estimate is 8.7, implying a prospective dividend yield of 8.1%.
Current consensus EPS estimate suggests the PER is 11.9.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ILU ILUKA RESOURCES LIMITED
Mineral Sands – Overnight Price: $7.01
Canaccord Genuity rates ((ILU)) as Sell (5) –
Iluka Resources' Sep Q mineral sands production missed Canaccord Genuity by -12%, with weak zircon and rutile production partially offset by strong synthetic rutile production.
Sales volumes significantly missed expectations with the miss evenly spread across all products, accompanied by a large inventory build, suggesting demand conditions continue to deteriorate.
The broker expects a rebound in sales volumes in the Dec Q but softer demand conditions persist in the near term.
Target falls to $7.00 from $7.90, Sell retained.
This report was published on October 25, 2023.
Target price is $7.00 Current Price is $7.01 Difference: minus $0.01 (current price is over target).
If ILU meets the Canaccord Genuity target it will return approximately minus 0% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $8.88, suggesting upside of 26.7%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 3.00 cents and EPS of 86.00 cents.
At the last closing share price the estimated dividend yield is 0.43%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 70.8, implying annual growth of -50.8%.
Current consensus DPS estimate is 6.5, implying a prospective dividend yield of 0.9%.
Current consensus EPS estimate suggests the PER is 9.9.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 7.00 cents and EPS of 73.00 cents.
At the last closing share price the estimated dividend yield is 1.00%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.60.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 82.8, implying annual growth of 16.9%.
Current consensus DPS estimate is 15.6, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 8.5.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IMD IMDEX LIMITED
Mining Sector Contracting – Overnight Price: $1.63
Canaccord Genuity rates ((IMD)) as Buy (1) –
Imdex' Sep Q trading update provided further evidence in Canaccord Genuity's view of recovering revenue growth as well as margin support, at a time when the stock is cheaper than it has been for several years.
The risk to numbers is that exploration budgets for 2024 remain fluid, with the potential for variance each way quite high. However, the early indications are positive, and the broker has not yet factored in an ongoing recovery in the second half.
An acceleration of earnings growth remains uncertain, but a stabilisation of earnings appears clear. Buy and $2.10 target retained.
This report was published on October 25, 2023.
Target price is $2.10 Current Price is $1.63 Difference: $0.47
If IMD meets the Canaccord Genuity target it will return approximately 29% (excluding dividends, fees and charges).
Current consensus price target is $1.84, suggesting upside of 13.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 3.30 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 2.02%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.30.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.2, implying annual growth of 40.9%.
Current consensus DPS estimate is 3.6, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 14.6.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 4.20 cents and EPS of 12.00 cents.
At the last closing share price the estimated dividend yield is 2.58%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.3, implying annual growth of 9.8%.
Current consensus DPS estimate is 3.8, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 13.3.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
INA INGENIA COMMUNITIES GROUP
Aged Care & Seniors – Overnight Price: $3.93
Goldman Sachs rates ((INA)) as Neutral (3) –
It is Goldman Sachs' opinion that the acquisition of Serenitas by Mirvac Group ((MGR)) supports its thesis of the attractive economics and long-term structural growth in land lease. With increasing capital entering the sector, the broker sees room for more players.
The broker retains its Neutral rating on Ingenia Communities, despite it being exposed to the same tailwinds as peers given the company is not a pure play. Ingenia Communities also retains a more complex operating model that has driven recent execution challenges.
The target price of $4.30 is retained.
This report was published on October 18, 2023.
Target price is $4.30 Current Price is $3.93 Difference: $0.37
If INA meets the Goldman Sachs target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $4.54, suggesting upside of 15.5%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 11.50 cents and EPS of 21.50 cents.
At the last closing share price the estimated dividend yield is 2.93%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.28.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.7, implying annual growth of 37.4%.
Current consensus DPS estimate is 11.1, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 18.1.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 13.10 cents and EPS of 24.60 cents.
At the last closing share price the estimated dividend yield is 3.33%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.98.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 28.3, implying annual growth of 30.4%.
Current consensus DPS estimate is 13.0, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 13.9.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
JHX JAMES HARDIE INDUSTRIES PLC
Building Products & Services – Overnight Price: $39.11
Jarden rates ((JHX)) as Downgrade to Neutral from Overweight (3) –
Jarden expects James Hardie Industries will deliver on December-quarter guidance but sees no room for upside given the weak US housing market and expects consumers will hold off on renovations and extensions.
The broker shaves June-half and FY25 margin forecasts to reflect low activity, a less favourable product mix (as builders shift to cheaper products) and freight costs.
Jarden now sits -8.7% below FY25 consensus forecasts. The broker suspects a softening economy could augur a further deterioration and observes the company is trading at the highest multiples of all building materials companies under its coverage (partly a reflection on its quality).
Rating is downgraded to Neutral from Overweight. Target price falls to $45.20 from $48.60.
This report was published on October 19, 2023.
Target price is $45.20 Current Price is $39.11 Difference: $6.09
If JHX meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $50.74, suggesting upside of 29.7%(ex-dividends)
The company's fiscal year ends in March.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 214.51 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 231.1, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 16.9.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 223.24 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 261.2, implying annual growth of 13.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 15.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LIC LIFESTYLE COMMUNITIES LIMITED
Aged Care & Seniors – Overnight Price: $15.46
Goldman Sachs rates ((LIC)) as Buy (1) –
It is Goldman Sachs' opinion that the acquisition of Serenitas by Mirvac Group ((MGR)) supports its thesis of the attractive economics and long-term structural growth in land lease. With increasing capital entering the sector, the broker sees room for more players.
The broker retains its Buy rating on Lifestyle Communities, noting the deferred fee structure that allows the company to capture more value from its growth pipeline, and visibility and confidence over a settlement ramp up through to FY26.
The target price of $25.25 is retained.
This report was published on October 18, 2023.
Target price is $25.25 Current Price is $15.46 Difference: $9.79
If LIC meets the Goldman Sachs target it will return approximately 63% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 17.10 cents and EPS of 79.40 cents.
At the last closing share price the estimated dividend yield is 1.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.47.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 21.20 cents and EPS of 115.30 cents.
At the last closing share price the estimated dividend yield is 1.37%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.41.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LNW LIGHT & WONDER INC
Gaming – Overnight Price: $124.72
Jarden rates ((LNW)) as Buy (1) –
Jarden believes there is upside operational earnings risk for Light & Wonder and Overweight-rated Aristocrat Leisure due to strong gross gaming revenue (GGR) growth, well-funded cashed up casino customers and strong replacement demand.
The broker also sees growth across both Gaming Operations (rental model) and Outright Sales and expects both companies will take market share. The gaming industry is considered strong after ten consecutive quarters of GGR growth, and is arguably resilient
The Buy rating and $136 target are maintained for Light & Wonder.
This report was published on October 20, 2023.
Target price is $136.00 Current Price is $124.72 Difference: $11.28
If LNW meets the Jarden target it will return approximately 9% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 0.00 cents and EPS of 129.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 96.46.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 359.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 34.65.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LRK LARK DISTILLING CO. LIMITED
Food, Beverages & Tobacco – Overnight Price: $1.48
Moelis rates ((LRK)) as Hold (3) –
Lark Distilling Co has provided further detail around its strategy for brand positioning, price architecture and product distribution at its recent investor day, notably targeting distribution into ten markets by the end of FY26.
It is Moelis' position that expansion into export markets is crucial to long-term success, and finds the target achievable. Moelis expects use of distribution partners will keep expansion capital-light, but does expect profitability from exports to be low for the foreseeable future.
The Hold rating is retained and the target price increases to $1.75 from $1.70.
This report was published on October 18, 2023.
Target price is $1.75 Current Price is $1.48 Difference: $0.27
If LRK meets the Moelis target it will return approximately 18% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 4.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 33.64.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 3.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 40.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MAP MICROBA LIFE SCIENCES LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.21
Canaccord Genuity rates ((MAP)) as Speculative Buy (1) –
Microba Life Sciences has announced the acquisition of Invivo Clinical, a UK microbiome testing business, which expands Microba's scale and international presence. Canaccord Genuity views this acquisition positively and as transformational for the company's diagnostics business.
The company sits in a very different position to where it was 12 months ago, the broker notes, now with a major strategic holder and distributor in Sonic Healthcare ((SHL)) and a much broader and deeper presence in the UK market, with the opportunity to expand in Australia, the US and beyond.
Speculative Buy and 44c target retained.
This report was published on October 25, 2023.
Target price is $0.44 Current Price is $0.21 Difference: $0.225
If MAP meets the Canaccord Genuity target it will return approximately 105% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MYX MAYNE PHARMA GROUP LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $3.93
Canaccord Genuity rates ((MYX)) as Hold (3) –
Mayne Pharma reported a positive Sep Q update following a few disappointing quarters. Canaccord Genuity views the performance as promising, with improvements at the top and bottom line across all segments.
The broker is cautiously optimistic, and looks forward to more consistency in performance around top line growth, gross to net pricing, and operational efficiency in the coming quarters.
Hold and $3.80 target retained.
This report was published on October 25, 2023.
Target price is $3.80 Current Price is $3.93 Difference: minus $0.13 (current price is over target).
If MYX meets the Canaccord Genuity target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((MYX)) as Underweight (5) –
Mayne Pharma's September-quarter trading update pleased Wilsons, the broker observing gross-to-net pricing appears to have normalised, and upgrades revenue forecasts.
Wilsons is cautious given volatility and the need for product launches but observes "incredible leverage" in the business given the company's recent underperformance, making small revenue upgrades material.
Rating is upgraded to Market Weight from Underweight. Target price rises 19% to $3.20 from $2.68.
This report was published on October 20, 2023.
Target price is $3.20 Current Price is $3.93 Difference: minus $0.73 (current price is over target).
If MYX meets the Wilsons target it will return approximately minus 19% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 84.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 4.66.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 55.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 7.08.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NCK NICK SCALI LIMITED
Furniture & Renovation – Overnight Price: $10.88
Jarden rates ((NCK)) as Underweight (4) –
Jarden assesses a solid AGM update by Nick Scali with the written order run-rate improving modestly in August and September.
Management's guidance for $40-42m of 1H profit, while down -31% year-on-year, still exceeded the consensus expectation by around 7%.
The broker forecasts an around -8% fall in 1H revenue, with a moderation in gross margin as higher promotions, a falling currency and easing freight tailwinds weigh.
The target rises to $10.30 from $9.70 on increased medium-term earnings forecasts and the Underweight rating is unchanged, though Jarden is becoming more positive on the outlook.
This report was published on October 20, 2023.
Target price is $10.30 Current Price is $10.88 Difference: minus $0.58 (current price is over target).
If NCK meets the Jarden target it will return approximately minus 5% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 59.20 cents and EPS of 90.10 cents.
At the last closing share price the estimated dividend yield is 5.44%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.08.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 61.80 cents and EPS of 94.00 cents.
At the last closing share price the estimated dividend yield is 5.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.57.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((NCK)) as Market Weight (3) –
Nick Scali's AGM net-profit-after-tax guidance missed Wilson's forecasts by -7%.
While the company's September-quarter trading update revealed an improvement in its like-for-like sales run rate over August and September (ahead of the broker), Wilsons finds it hard to get excited given the weak economic outlook and the guidance downgrade.
The broker suspects gross margins could be under pressure given extended promotional periods and observes visibility is becoming increasingly opaque. Foot traffic fell but conversions rose due to "value" offerings.
Market Weight rating retained. Target price falls to $11.30 from $12.20.
This report was published on October 20, 2023.
Target price is $11.30 Current Price is $10.88 Difference: $0.42
If NCK meets the Wilsons target it will return approximately 4% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 50.90 cents and EPS of 84.70 cents.
At the last closing share price the estimated dividend yield is 4.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.85.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 52.00 cents and EPS of 86.60 cents.
At the last closing share price the estimated dividend yield is 4.78%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.56.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NST NORTHERN STAR RESOURCES LIMITED
Gold & Silver – Overnight Price: $12.10
Canaccord Genuity rates ((NST)) as Buy (1) –
Northern Star Resources' group sales and costs were largely in line with Canaccord Genuity, with the quarter flagged to be a weak one with major planned shutdowns across all three production hubs.
The broker continues to expect a strong recovery over the remainder of the year and forecasts a second half production skew of 53%.
The broker notes both Thunderbox and Pogo plants running at nameplate as well as waste material movements at KCGM remain on track to access high-grade ore.
Buy and $13.95 target retained.
This report was published on October 25, 2023.
Target price is $13.95 Current Price is $12.10 Difference: $1.85
If NST meets the Canaccord Genuity target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $12.60, suggesting upside of 4.1%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 28.00 cents and EPS of 48.00 cents.
At the last closing share price the estimated dividend yield is 2.31%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.21.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 50.5, implying annual growth of -0.6%.
Current consensus DPS estimate is 31.8, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 24.0.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 31.00 cents and EPS of 95.00 cents.
At the last closing share price the estimated dividend yield is 2.56%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.74.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 67.5, implying annual growth of 33.7%.
Current consensus DPS estimate is 35.6, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 17.9.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NWL NETWEALTH GROUP LIMITED
Wealth Management & Investments – Overnight Price: $12.72
Jarden rates ((NWL)) as Underweight (4) –
Netwealth Group's custodial net flows in the 1Q fell short of expectations held by both Jarden and consensus, with elevated outflows remaining the key issue, particularly across higher net worth clients.
Gross inflows softened materially to $4.7bn after a record prior quarter of $6.2bn, and gross outflows of -$2.7bn remained elevated at 15.3% per annum of funds under administration (FUA).
These outflows reflect market volatility and a shift to off-platform term deposits, suggests the broker, and risks to net flows remain skewed to the downside.
The target edges down to $13.80 from $13.85 and the Underweight rating is unchanged.
This report was published on October 20, 2023.
Target price is $13.80 Current Price is $12.72 Difference: $1.08
If NWL meets the Jarden target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $14.71, suggesting upside of 15.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 29.00 cents and EPS of 34.10 cents.
At the last closing share price the estimated dividend yield is 2.28%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.30.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 34.0, implying annual growth of 23.5%.
Current consensus DPS estimate is 28.3, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 37.4.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 34.80 cents and EPS of 41.00 cents.
At the last closing share price the estimated dividend yield is 2.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.02.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 41.0, implying annual growth of 20.6%.
Current consensus DPS estimate is 34.1, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 31.0.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((NWL)) as Overweight (1) –
Netwealth Group's September-quarter result missed Wilsons's forecast by -2% due to falling equity markets and weak net inflows.
The broker observes outflow rates moderated but remain above historical averages, the group continuing to haemorrhage larger accounts (50% of total September-quarter outflows).
Wilsons expects outflows will ease once the tightening cycle rolls off and remains constructive.
EPS forecast fall -6% to -8% across FY23 to FY26.
Overweight rating retained. Target price falls to $15.38 from $16.29.
This report was published on October 20, 2023.
Target price is $15.38 Current Price is $12.72 Difference: $2.66
If NWL meets the Wilsons target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $14.71, suggesting upside of 15.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 28.00 cents and EPS of 32.90 cents.
At the last closing share price the estimated dividend yield is 2.20%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 38.66.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 34.0, implying annual growth of 23.5%.
Current consensus DPS estimate is 28.3, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 37.4.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 36.10 cents and EPS of 42.50 cents.
At the last closing share price the estimated dividend yield is 2.84%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 29.93.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 41.0, implying annual growth of 20.6%.
Current consensus DPS estimate is 34.1, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 31.0.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PLS PILBARA MINERALS LIMITED
New Battery Elements – Overnight Price: $3.88
Canaccord Genuity rates ((PLS)) as Buy (1) –
Port data for the September quarter indicates Pilbara Minerals made one shipment in July and August, and four in September. Canaccord Genuity has updated its model for shipped tonnes and pricing, given the majority of shipping occurred towards the end of the quarter.
Buy and $5.10 target retained.
This report was published on October 25, 2023.
Target price is $5.10 Current Price is $3.88 Difference: $1.22
If PLS meets the Canaccord Genuity target it will return approximately 31% (excluding dividends, fees and charges).
Current consensus price target is $5.00, suggesting upside of 28.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 33.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.76.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 54.0, implying annual growth of -32.4%.
Current consensus DPS estimate is 11.3, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 7.2.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 7.00 cents and EPS of 43.00 cents.
At the last closing share price the estimated dividend yield is 1.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.02.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 59.0, implying annual growth of 9.3%.
Current consensus DPS estimate is 14.9, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 6.6.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PMT PATRIOT BATTERY METALS INC
Mining – Overnight Price: $1.19
Canaccord Genuity rates ((PMT)) as Speculative Buy (1) –
Patriot Battery Metals has announced the discovery of a new high-grade zone within its Corvette project in Quebec. The discovery was a part of the first series of drill holes completed at CV13 during the 2023 summer-fall program.
The results to date continue to inform overall mine planning and design for both pegmatites, Canaccord Genuity notes, with the possibility that CV5 and CV13 form one continuous pegmatite body subsurface creating several options for the starter pit.
Speculative Buy and CA$17.00 target retained.
This report was published on October 25, 2023.
Current Price is $1.19. Target price not assessed.
This company reports in CAD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PPS PRAEMIUM LIMITED
Wealth Management & Investments – Overnight Price: $0.55
Canaccord Genuity rates ((PPS)) as Buy (1) –
Praemium reported Sep Q funds under management only marginally below Canaccord Genuity's forecast.
The quarter had been adversely impacted by a -$0.4bn outflow attributable to eight adviser departures from platform clients during the period, including seven from major client in Escala.
The broker notes also that FUA related to Virtual Managed Account admin services increased, reflecting growth in the number of client portfolios accessing portfolio administration & reporting services, and this is before the impact of a meaningful new client in Mercer, as announced in September.
Buy and $1.20 target retained.
This report was published on October 25, 2023.
Target price is $1.20 Current Price is $0.55 Difference: $0.65
If PPS meets the Canaccord Genuity target it will return approximately 118% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 1.00 cents and EPS of 4.00 cents.
At the last closing share price the estimated dividend yield is 1.82%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.75.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 1.50 cents and EPS of 5.00 cents.
At the last closing share price the estimated dividend yield is 2.73%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.00.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Moelis rates ((PPS)) as Buy (1) –
Having updated on its September quarter, Moelis describes strong Separately Managed Account (SMA) flows, compared to expectations, as a key positive of the period. As the broker points out, SMA flows are higher margin and can have greater influence on revenue.
The company did introduce a number of platform functionality enhancements during the quarter, and further enhancements are anticipated throughout the financial year.
The Buy rating is retained and the target price increases to 93 cents from 92 cents.
This report was published on October 18, 2023.
Target price is $0.93 Current Price is $0.55 Difference: $0.38
If PPS meets the Moelis target it will return approximately 69% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 1.60 cents and EPS of 2.70 cents.
At the last closing share price the estimated dividend yield is 2.91%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.37.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 1.90 cents and EPS of 3.20 cents.
At the last closing share price the estimated dividend yield is 3.45%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.19.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((PPS)) as Overweight (1) –
Praemium's Q1 trading update showed signs of ongoing health for gross inflows, notes Wilsons, with outflow rates also suggesting moderation through the quarter.
Funds under administration (FUA) only slightly missed the broker's expectation, driven by a weaker September market performance and one-off outflows for Powerwrap.
The target falls to 86c from 89c. Industry data suggest system gross inflows remain healthy, note the analysts, with Praemium continuing to take its historical level of share. Overweight.
This report was published on October 19, 2023.
Target price is $0.86 Current Price is $0.55 Difference: $0.31
If PPS meets the Wilsons target it will return approximately 56% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 2.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.97.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 3.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.86.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RDY READYTECH HOLDINGS LIMITED
Software & Services – Overnight Price: $3.57
Jarden rates ((RDY)) as Overweight (2) –
At the company's investor day, ReadyTech Holdings' management highlighted the company's quality and growth opportunities, observes Jarden.
In particular, low churn, rising annual recurring revenue, vertical-specific SaaS offering, and defensive end-market all combined to paint a positive picture as did the company's strong M&A platform.
While Jarden retains its Overweight rating, the broker cuts the target price to $3.65 from $3.89 after downgrading earnings (EBITDA) forecasts to reflect increased operating expenditure related to the IT Vison acquisition and onboarding; and a rebasing of revenue forecasts following the FY23 results.
This report was published on October 19, 2023.
Target price is $3.65 Current Price is $3.57 Difference: $0.08
If RDY meets the Jarden target it will return approximately 2% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 EPS of 13.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.06.
Forecast for FY25:
Jarden forecasts a full year FY25 EPS of 17.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.94.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((RDY)) as Overweight (1) –
Analaysts at Wilsons came away from ReadyTech Holdings' investor day expecting FY24 guidance will be reaffirmed at the AGM in November. Management is expecting an increased, higher-value-customer win-rate.
The broker suggests increased Federal government funding and competitor M&A will likely result in elusive TAFE wins over the medium-term. Funding is expected to stimulate incremental investment into SMS and digital solutions as TAFE budget’s increasingly free-up.
Overweight rating retained. Target price steady at $4.04.
This report was published on October 19, 2023.
Target price is $4.04 Current Price is $3.57 Difference: $0.47
If RDY meets the Wilsons target it will return approximately 13% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 15.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.45.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 20.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.50.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RED RED 5 LIMITED
Gold & Silver – Overnight Price: $0.31
Canaccord Genuity rates ((RED)) as Hold (3) –
Red 5's Sep Q production was a beat on Canaccord Genuity's forecast as were costs, which came in lower than the guidance range.
FY24 cost guidance has nonetheless been maintained as well as growth capex, with management noting it is on track to deliver at the top end of the production guidance range.
The broker retains Hold on valuation but highlights Red 5's recent outperformance relative to peers. Target unchanged at 32c.
This report was published on October 25, 2023.
Target price is $0.32 Current Price is $0.31 Difference: $0.01
If RED meets the Canaccord Genuity target it will return approximately 3% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 1.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.00.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.50.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Petra Capital rates ((RED)) as Buy (1) –
Red 5's September-quarter result appears to have outpaced Petra Capital's forecasts, with all-in-sustaining costs proving the main beat, and the broker observes the company is on a trajectory towards the top end of guidance.
Given the positive gold-price backdrop, the broker expects strong free cash flow should swiftly bump up the balance sheet, allowing dividend payments from FY25.
Noting the strong performance and the strong strategic value of KOTH in a rapidly consolidating region, the broker raises its target price to 40c from 34c.
Buy rating retained, the broker considering the company to offer strong value relative to small peers.
This report was published on October 19, 2023.
Target price is $0.40 Current Price is $0.31 Difference: $0.09
If RED meets the Petra Capital target it will return approximately 29% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of 2.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.92.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.40.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RFG RETAIL FOOD GROUP LIMITED
Food, Beverages & Tobacco – Overnight Price: $0.05
Petra Capital rates ((RFG)) as Buy (1) –
Petra Capital highlights building the portfolio of corporate stores, which now account for around 16% of group revenue, is an underplayed aspect of Retail Food's growth strategy.
As a result of these corporate stores, a greater slice of network sales is now expected to fall to the earnings (EBITDA) line in the P&L statement.
Apart from greater profitability (and higher risk) compared to franchisee stores, operating corporate stores helps set a retail standard across the group and aides testing of new initiates prior to a roll-out to franchisees, explains the broker.
Additionally, the analyst highlights this policy allows retention of good sites when franchisees decide not to renew, and also provides direct access/exposure to end customers.
The Buy rating and 9c target are unchanged.
This report was published on October 20, 2023.
Target price is $0.09 Current Price is $0.05 Difference: $0.043
If RFG meets the Petra Capital target it will return approximately 91% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Petra Capital forecasts a full year FY24 dividend of 0.20 cents and EPS of 0.90 cents.
At the last closing share price the estimated dividend yield is 4.26%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.22.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.40 cents and EPS of 1.03 cents.
At the last closing share price the estimated dividend yield is 8.51%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.56.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RWC RELIANCE WORLDWIDE CORP. LIMITED
Building Products & Services – Overnight Price: $3.41
Goldman Sachs rates ((RWC)) as Buy (1) –
Goldman Sachs has reviewed its outlook on Reliance Worldwide, with housing starts revised down for both Australia and the US.
For these regions respectively starts were lowered -3% and -8% for 2023, and -8% and -2% for 2024. The broker does not consider these changes material.
Goldman Sachs points out while the housing industry is increasingly facing headwinds, an undersupply of homes in the US continues.
The Buy rating is retained and the target price decreases to $4.35 from $4.50.
This report was published on October 18, 2023.
Target price is $4.35 Current Price is $3.41 Difference: $0.94
If RWC meets the Goldman Sachs target it will return approximately 28% (excluding dividends, fees and charges).
Current consensus price target is $4.17, suggesting upside of 22.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 EPS of 27.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 28.1, implying annual growth of N/A.
Current consensus DPS estimate is 13.9, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 12.1.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 EPS of 30.11 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.33.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 31.9, implying annual growth of 13.5%.
Current consensus DPS estimate is 16.3, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 10.7.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
STO SANTOS LIMITED
NatGas – Overnight Price: $7.77
Jarden rates ((STO)) as Neutral (3) –
Following a broadly in-line 3Q result for Santos, with strong free cash flow (FCF), Jarden maintains focus on challenges for Barossa LNG around obtaining an Environment Plan, and impacts on costs and the timeline.
Production for the quarter was 1% ahead of the consensus estimate on higher oil production in PNG and higher output from Bayu-Undan. Sales revenue also exceeded the broker's forecast by 1% due to higher volumes and higher realised oil prices.
All FY23 guidance was left unchanged by management.
The broker's target falls to $7.95 from $8.05 due to a higher assumed risk-free interest rate. Neutral.
This report was published on October 20, 2023.
Target price is $7.95 Current Price is $7.77 Difference: $0.18
If STO meets the Jarden target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $9.52, suggesting upside of 22.5%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 25.29 cents and EPS of 68.79 cents.
At the last closing share price the estimated dividend yield is 3.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.29.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 74.3, implying annual growth of N/A.
Current consensus DPS estimate is 31.7, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 10.5.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 37.03 cents and EPS of 69.10 cents.
At the last closing share price the estimated dividend yield is 4.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.25.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 77.7, implying annual growth of 4.6%.
Current consensus DPS estimate is 34.2, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 10.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
THL TOURISM HOLDINGS LIMITED
Travel, Leisure & Tourism – Overnight Price: $3.12
Jarden rates ((THL)) as Overweight (2) –
After reviewing key operating metrics following 1Q results, Jarden shares the optimism of Tourism Holdings Rentals, which is now aiming for a profit of $100m in FY26 via organic growth and synergies.
Above and beyond this target, management intends to pursue M&A opportunities. The company confirmed FY23's pro forma profit of $81.1m, adjusted for merger accounting, is a "good starting point" and remains "positive about the opportunity for growth in FY24".
No 1H guidance was provided but management noted one-offs will see profit weighted to the 2H.
The target rises to NZ$4.66 from NZ$4.60 and the Overweight rating is unchanged.
This report was published on October 20, 2023.
Current Price is $3.12. Target price not assessed.
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 17.66 cents and EPS of 35.32 cents.
At the last closing share price the estimated dividend yield is 5.66%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.83.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 19.88 cents and EPS of 39.77 cents.
At the last closing share price the estimated dividend yield is 6.37%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.85.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((THL)) as Overweight (1) –
Following an AGM trading update, Wilsons assesses FY24 is on track for Tourism Holdings Rentals or may even be marginally bettered.
Management stated FY23 pro forma profit of NZ$77.1m is a “good starting point”, with the company positive on growth in FY24 and beyond.
Positively, RV rental supply is still well below the pre-covid level, observes the analyst, and management suspects recovery will take several years. The RV recovery is trailing behind the recovery in international airline capacity.
The Overweight rating and $5.29 target are retained.
This report was published on October 20, 2023.
Target price is $5.29 Current Price is $3.12 Difference: $2.17
If THL meets the Wilsons target it will return approximately 70% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 15.81 cents and EPS of 35.24 cents.
At the last closing share price the estimated dividend yield is 5.07%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.85.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 18.40 cents and EPS of 40.97 cents.
At the last closing share price the estimated dividend yield is 5.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.62.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TLX TELIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $8.94
Jarden rates ((TLX)) as Buy (1) –
Telix Pharmaceuticals' September-quarter revenue appears to have missed Jarden's forecasts, although revenue by -4.5%, suggesting an acceleration will be required to meet guidance, says the broker.
Margins were stable and tracking a touch lower (63%) than Jarden's forecasts (64%) and operating expenditure was a miss, but the broker sheets this back to the unpredictable nature of regulatory submissions and trial activity.
Cash flow remained positive and outpaced Jarden's forecasts.
Buy rating and $12.99 target price retained. In a follow-up update, the following day, the target was lowered to $12.69 from $12.99.
This report was published on October 19, 2023.
Target price is $12.69 Current Price is $8.94 Difference: $3.75
If TLX meets the Jarden target it will return approximately 42% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 0.00 cents and EPS of 23.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.56.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 45.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.65.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((TLX)) as Overweight (1) –
Telix Pharmaceuticals September-quarter result outpaced Wilsons's forecasts, thanks to a strong beat from global ILLUCCIX sales.
The company closed the quarter with $137.4m cash and operating cash flow of $21.4m. Wilsons observes the company is full funds to execute on its strategy over the next two years.
The broker considers the post-update retreat in the share-price to be premature.
Overweight rating retained. Target price rises to $13.25 from $13.13.
This report was published on October 20, 2023.
Target price is $13.13 Current Price is $8.94 Difference: $4.19
If TLX meets the Wilsons target it will return approximately 47% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY23:
Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of 13.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 67.73.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 25.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 34.92.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TRS REJECT SHOP LIMITED
Household & Personal Products – Overnight Price: $5.54
Jarden rates ((TRS)) as Buy (1) –
Reject Shop's AGM met Jarden's forecasts, management providing an upbeat trading update, observing like for like sales trends continue to improve, along with consumable inflation, increased cross-shopping and a growing cohort of value-focused customers as inflation bites.
The broker considers the company to be well-positioned to outperform given the above dynamics.
Buy rating and $7 target price retained.
This report was published on October 19, 2023.
Target price is $7.00 Current Price is $5.54 Difference: $1.46
If TRS meets the Jarden target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $6.15, suggesting upside of 11.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 17.00 cents and EPS of 28.20 cents.
At the last closing share price the estimated dividend yield is 3.07%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.65.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 32.2, implying annual growth of 18.6%.
Current consensus DPS estimate is 19.5, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 17.2.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 32.00 cents and EPS of 51.60 cents.
At the last closing share price the estimated dividend yield is 5.78%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.74.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 36.7, implying annual growth of 14.0%.
Current consensus DPS estimate is 22.0, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 15.1.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
VIT VITURA HEALTH LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.36
Petra Capital rates ((VIT)) as Buy (1) –
In aiming to reduce dependence on revenue from medicinal cannabis, Vitura Health will outlay -$25m (using a mixture of cash, deferred cash payments and equity) to acquire Doctors on Demand Pty Ltd.
The digital telehealth platform, which conducts 280,000 consults per year, facilitates GP consultations via teleconference.
The broker raises its revenue, earnings and profit projections, resulting in a 70c target, up from 66c. The Buy rating is unchanged.
This report was published on October 20, 2023.
Target price is $0.70 Current Price is $0.36 Difference: $0.34
If VIT meets the Petra Capital target it will return approximately 94% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
WDS WOODSIDE ENERGY GROUP LIMITED
NatGas – Overnight Price: $34.89
Jarden rates ((WDS)) as Underweight (4) –
Woodside Energy's September-quarter production missed Jarden's forecasts due to lower than expected volumes from the North West Shelf, Mad Dog, Shenzi and Bass Straight. Pluto outdid itself but only managed to partly offset the fall in output from its cousins.
All up, production was up 8% quarter on quarter.
Management narrowed production guidance, cut capital expenditure guidance, and reiterated that Scarborough was on track for a 2026 start-up, despite recent challenges.
Underweight rating retained. Target price eases to $34.90 from $35.000
This report was published on October 19, 2023.
Target price is $34.90 Current Price is $34.89 Difference: $0.01
If WDS meets the Jarden target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $36.82, suggesting upside of 5.5%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 204.73 cents and EPS of 257.26 cents.
At the last closing share price the estimated dividend yield is 5.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 256.9, implying annual growth of N/A.
Current consensus DPS estimate is 196.1, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 13.6.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 236.34 cents and EPS of 296.85 cents.
At the last closing share price the estimated dividend yield is 6.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 271.6, implying annual growth of 5.7%.
Current consensus DPS estimate is 203.5, implying a prospective dividend yield of 5.8%.
Current consensus EPS estimate suggests the PER is 12.8.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: 29M - 29METALS LIMITED
For more info SHARE ANALYSIS: A11 - ATLANTIC LITHIUM LIMITED.
For more info SHARE ANALYSIS: A1N - ARN MEDIA LIMITED
For more info SHARE ANALYSIS: ALL - ARISTOCRAT LEISURE LIMITED
For more info SHARE ANALYSIS: AMP - AMP LIMITED
For more info SHARE ANALYSIS: ARB - ARB CORPORATION LIMITED
For more info SHARE ANALYSIS: AVH - AVITA MEDICAL INC
For more info SHARE ANALYSIS: BHP - BHP GROUP LIMITED
For more info SHARE ANALYSIS: BPT - BEACH ENERGY LIMITED
For more info SHARE ANALYSIS: CCP - CREDIT CORP GROUP LIMITED
For more info SHARE ANALYSIS: CCR - CREDIT CLEAR LIMITED
For more info SHARE ANALYSIS: CNB - CARNABY RESOURCES LIMITED
For more info SHARE ANALYSIS: COI - COMET RIDGE LIMITED
For more info SHARE ANALYSIS: CTD - CORPORATE TRAVEL MANAGEMENT LIMITED
For more info SHARE ANALYSIS: CTT - CETTIRE LIMITED
For more info SHARE ANALYSIS: CUV - CLINUVEL PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: EEG - EMPIRE ENERGY GROUP LIMITED
For more info SHARE ANALYSIS: EVN - EVOLUTION MINING LIMITED
For more info SHARE ANALYSIS: EVT - EVT LIMITED
For more info SHARE ANALYSIS: EXP - EXPERIENCE CO LIMITED
For more info SHARE ANALYSIS: GOZ - GROWTHPOINT PROPERTIES AUSTRALIA
For more info SHARE ANALYSIS: HDN - HOMECO DAILY NEEDS REIT
For more info SHARE ANALYSIS: ILU - ILUKA RESOURCES LIMITED
For more info SHARE ANALYSIS: IMD - IMDEX LIMITED
For more info SHARE ANALYSIS: INA - INGENIA COMMUNITIES GROUP
For more info SHARE ANALYSIS: JHX - JAMES HARDIE INDUSTRIES PLC
For more info SHARE ANALYSIS: LIC - LIFESTYLE COMMUNITIES LIMITED
For more info SHARE ANALYSIS: LNW - LIGHT & WONDER INC
For more info SHARE ANALYSIS: LRK - LARK DISTILLING CO. LIMITED
For more info SHARE ANALYSIS: MAP - MICROBA LIFE SCIENCES LIMITED
For more info SHARE ANALYSIS: MGR - MIRVAC GROUP
For more info SHARE ANALYSIS: MYX - MAYNE PHARMA GROUP LIMITED
For more info SHARE ANALYSIS: NCK - NICK SCALI LIMITED
For more info SHARE ANALYSIS: NST - NORTHERN STAR RESOURCES LIMITED
For more info SHARE ANALYSIS: NWL - NETWEALTH GROUP LIMITED
For more info SHARE ANALYSIS: PLS - PILBARA MINERALS LIMITED
For more info SHARE ANALYSIS: PMT - PATRIOT BATTERY METALS INC
For more info SHARE ANALYSIS: PPS - PRAEMIUM LIMITED
For more info SHARE ANALYSIS: RDY - READYTECH HOLDINGS LIMITED
For more info SHARE ANALYSIS: RED - RED 5 LIMITED
For more info SHARE ANALYSIS: RFG - RETAIL FOOD GROUP LIMITED
For more info SHARE ANALYSIS: RWC - RELIANCE WORLDWIDE CORP. LIMITED
For more info SHARE ANALYSIS: SHL - SONIC HEALTHCARE LIMITED
For more info SHARE ANALYSIS: STO - SANTOS LIMITED
For more info SHARE ANALYSIS: SXL - SOUTHERN CROSS MEDIA GROUP LIMITED
For more info SHARE ANALYSIS: THL - TOURISM HOLDINGS LIMITED
For more info SHARE ANALYSIS: TLX - TELIX PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: TRS - REJECT SHOP LIMITED
For more info SHARE ANALYSIS: VIT - VITURA HEALTH LIMITED
For more info SHARE ANALYSIS: WDS - WOODSIDE ENERGY GROUP LIMITED